OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

9480	Companies
185563	Keywords
117969	Articles
99399	Press releases

Home
Companies
OXURION

BRIEF

published on 06/18/2025 at 18:05, 5 months 17 days ago

Oxurion annonce une notification de transparence de la part d'Atlas Special Opportunities II LLC

Biopharmaceutique Notification De Transparence Oxurion Opportunités Spéciales Atlas Structure De Propriété
PRESS RELEASE

published on 06/18/2025 at 18:00, 5 months 17 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV announces receipt of transparency notification from Atlas Special Opportunities II, LLC regarding shareholding. Company combines therapeutic innovation with technology for clinical research

Clinical Research Transparency Notification Biopharmaceutical Belgium Oxurion NV
PRESS RELEASE

published on 06/18/2025 at 18:00, 5 months 17 days ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC, verlaagt aandeel tot onder drempel 20%. Biofarmaceutisch bedrijf in Leuven kondigt belangrijke ontwikkeling aan

Transparantiekennisgeving Oxurion NV Biofarmaceutisch België Atlas Special Opportunities II LLC
BRIEF

published on 06/12/2025 at 18:05, 5 months 23 days ago

Oxurion Reports Transparency Notification Amendments

Transparency Notification Biopharmaceutical Industry Shareholding Changes Oxurion NV Atlas Special Opportunities II
BRIEF

published on 06/12/2025 at 18:05, 5 months 23 days ago

Oxurion annonce des modifications à sa notification de transparence

Industrie Biopharmaceutique Notification De Transparence Oxurion NV Changements Dans L'actionnariat Atlas Opportunités Spéciales II
PRESS RELEASE

published on 06/12/2025 at 18:00, 5 months 23 days ago

Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received transparency notifications from Atlas Special Opportunities II, LLC regarding its share ownership crossing thresholds under Belgian Transparency legislation. Oxurion is a biopharmaceutical company focusing on therapeutic innovation and clinical research technologies

Clinical Research Transparency Notification Biopharmaceutical Oxurion NV Belgian Legislation
PRESS RELEASE

published on 06/12/2025 at 18:00, 5 months 23 days ago

Oxurion ontvangt aangepaste transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC over aankoop en verkoop van aandelen en stemrechtverlenende effecten volgens Belgische transparantiewetgeving

Transparantiekennisgevingen Aandelen Oxurion NV Belgische Transparantiewetgeving Atlas Special Opportunities II LLC
BRIEF

published on 06/12/2025 at 08:35, 5 months 23 days ago

Oxurion progresse dans son acquisition d'Axiodis

Acquisition Sciences De La Vie Oxurion Axiodis FDI France
BRIEF

published on 06/12/2025 at 08:35, 5 months 23 days ago

Oxurion progresses in its acquisition of Axiodis

Acquisition Life Sciences Oxurion Axiodis FDI France
PRESS RELEASE

published on 06/12/2025 at 08:30, 5 months 23 days ago

Oxurion avance dans l'acquisition projetée d'Axiodis
Oxurion NV lève la condition suspensive relative au droit d'information préalable des salariés, avançant vers l'acquisition d'Axiodis CRO. Discussions en cours pour créer des synergies stratégiques. Oxurion se concentre sur la finalisation de l'opération

Acquisition Biopharmaceutique Donnée Clinique Oxurion NV Synergies Stratégiques

Accesswire

Published on 12/06/2025 at 01:15, 13 minutes ago

Prospect Ridge Announces Closing of Flow-Through Unit Private Placement
Published on 12/06/2025 at 00:25, 1 hour 3 minutes ago

GMV Minerals Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/06/2025 at 00:00, 1 hour 28 minutes ago

Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 1 hour 58 minutes ago

55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000
Published on 12/05/2025 at 22:50, 2 hours 38 minutes ago

Banyan Gold Grants Incentive Stock Options

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 3 hours 12 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 3 hours 16 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 6 hours 30 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 7 hours 2 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 7 hours 13 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 23:00, 2 hours 28 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 2 hours 28 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 2 hours 28 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 2 hours 28 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 8 hours 10 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible

View all LES ECHOS COMFI WIRE